AbCellera Biologics Inc.ABCLNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank29
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P29
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
2025-6.98-31.8%
2024-5.30+53.0%
2023-11.28-161.9%
202218.22-29.1%
202125.70-71.6%
202090.63+101.6%
2019-5738.55-119.9%
201828795.02-